Skip to main content
Clinical Trials/ITMCTR2000004019
ITMCTR2000004019
Recruiting
Phase 1

Clinical study of music therapy in patients with lung cancer complicated with anxiety

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Lung malignancy has been histopathologically or cytologically confirmed, and anxiety related to cancer treatment or cancer itself is \>\= 2 months and \<\= 1 year;
  • 2\. Meet the standard of anxiety in HAMA \>\= 7 and \<\= 56; PS 0\-1 points;
  • 3\. Ages 18\-74, BMI between 18\.5 and 23\.9;
  • 4\. No history of chronic gastrointestinal diseases;No history of gastrointestinal surgery;No history of other mental illness; Did not take psychiatric drugs;No bad habits such as tobacco and alcohol;
  • 5\. Clear consciousness, normal behavior and hearing, no professional music background;Heart, liver, kidney, blood tests and other indicators are within the normal range;
  • 6\. No anti\-anxiety drugs, antibiotics, non\-steroidal drugs, microecological agents, gastrointestinal motional drugs, etc., were used in the past 4 weeks;
  • 7\. Regular three meals within the last 4 weeks, with meat and vegetable matching, no overeating, and control caffeine intake;
  • 8\. The expected survival time is more than 6 months;
  • 9\. Those who agree to participate in the study and sign the informed consent.

Exclusion Criteria

  • 1\. Participating in other clinical studies or clinical trials;
  • 2\. Patients with other serious diseases, such as infection, liver and kidney failure, who are considered by the project leader or researchers to be unable to tolerate the treatment regimen of this study;
  • 3\. Primary or metastatic brain tumors confirmed clinically or radiologically;
  • 4\. Pregnant or lactating women;
  • 5\. Participants received music therapy within 3 months prior to study;
  • 6\. Taking other anxiety medications or medications that affect anxiety.

Outcomes

Primary Outcomes

Not specified

Similar Trials